Jochen Maas
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in ⓘ
-
- Pharmacogenetics and Drug Metabolism 3
-
- Pharmaceutical studies and practices 3
- Co-authors
- Edward A. Sausville (1 shared paper)J I Johnson (1 shared paper)Peter J. Elliott (1 shared paper)Christine Pien (1 shared paper)Antonia T. Destree (1 shared paper)Vito J. Palombella (1 shared paper)Douglas Lazarus (1 shared paper)Julian Adams (1 shared paper)
- Journals
- Regulatory Toxicology and Pharmacology (2 papers)Schizophrenia Bulletin (1 paper)Clinical Pharmacology & Therapeutics (1 paper)EMBO Molecular Medicine (1 paper)Drug Metabolism Reviews (1 paper)
- Partner nations
- GermanyFranceNetherlands
In The Last Decade
Jochen Maas
18 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Hematology 341
- Oncology 554
- Molecular Biology 1.1k
- Pharmacology 114
- Hepatology 88
Countries citing papers authored by Jochen Maas
This map shows the geographic impact of Jochen Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Maas more than expected).
Fields of papers citing papers by Jochen Maas
This network shows the impact of papers produced by Jochen Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Maas. The network helps show where Jochen Maas may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Maas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Proteasome inhibitors: a novel class of potent and effective antitumor agents. Hit paper breakdown → | 1999 | 1188 |
| 2 | 2003 | 200 | |
| 3 | 2013 | 77 | |
| 4 | 2006 | 68 | |
| 5 | 2006 | 44 | |
| 6 | 2010 | 36 | |
| 7 | 2006 | 34 | |
| 8 | 1998 | 27 | |
| 9 | 2002 | 23 | |
| 10 | 2000 | 20 | |
| 11 | 2006 | 17 | |
| 12 | 2000 | 13 | |
| 13 | 2002 | 10 | |
| 14 | 2019 | 8 | |
| 15 | 1988 | 5 | |
| 16 | Jackknife stability of a tractor semi-trailer combination | 2007 | 4 |
| 17 | 2012 | 4 | |
| 18 | 2024 | 1 |
About Jochen Maas
Jochen Maas is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Radiation Dose and Imaging (2 papers), Pancreatic function and diabetes (1 paper), Drug Solubulity and Delivery Systems (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Vehicle Dynamics and Control Systems (1 paper). The work is most often cited by research in Hematology (341 citations), Oncology (554 citations), Molecular Biology (1.1k citations), Pharmacology (114 citations) and Hepatology (88 citations). Jochen Maas has collaborated with scholars based in Germany, France and Netherlands. Frequent co-authors include Edward A. Sausville, J I Johnson, Peter J. Elliott, Christine Pien, Antonia T. Destree, Vito J. Palombella, Douglas Lazarus, Julian Adams, Hannes Vogel and Franz J. Hock. Their work appears in journals such as Regulatory Toxicology and Pharmacology, Schizophrenia Bulletin, Clinical Pharmacology & Therapeutics, EMBO Molecular Medicine and Drug Metabolism Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.